Latest News
Oxford Performance Materials Acquires Ketonex High Performance PAEK Patent Portfolio
Wednesday 23 November 2022

US-based polymer science, coating technologies and 3D-printed biomedical devices specialist Oxford Performance Materials, Inc has inked an agreement to acquire the patent portfolio of England's Ketonex, Ltd., which is comprised of the world's highest performance PAEK polymer synthesis technology, the company said.

In adding these synthesis patents to its existing portfolio, OPM has furthered its capabilities as a recognized leader in PAEK (polyaryletherketone) materials technology, with broad applications in the biomedical, industrial, aerospace, energy, and electronics industries.

OPM began working with Ketonex over a decade ago. During those years the companies collaborated on the initial scale-up and development of the Ketonex polymer synthesis technologies.

In early 2022 this work reached critical technical and commercial milestones, which led to the acquisition.

The Ketonex technology was built upon a low temperature PAEK synthesis method that produced high quality PAEK products.

Originally commercialized by BASF, adoption was limited due to costly production methods.

Ketonex subsequently improved upon existing PAEK production efficiencies and patented an advanced process.

The Ketonex technology provides substantial advantages over other PAEK synthesis methods that produce materials such as PEEK and conventionally produced PEKK, as originally invented by DuPont.

The patented Ketonex low temperature synthesis method produces polymers with excellent stability, purity, controlled morphology, and product reproducibility.

Terms of the transaction were not disclosed. Legal services were provided by Updike Kelly Spellacy.

Oxford Performance Materials was founded in 2000 to exploit and commercialize the world's highest performing thermoplastic, PEKK (poly-ether-ketone-ketone).

OPM's Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK brand, including coating technologies for a range of industrial and biomedical applications.

OPM is in 3D printing. OPM's OsteoFab technology is in commercial production in numerous orthopedic implant applications, including cranial, facial, spinal, and sports medicine devices, and OPM's OXFAB production parts are designed for highly demanding industrial applications.

Founded in 2009, Ketonex is a developer of proprietary synthesis methods for PAEK thermoplastics. PAEK polymers are used in demanding applications in industrial, biomedical, aerospace and energy markets.
Date Published: 23/11/2022